Rigel Pharmaceuticals, Inc. (RIGL)

Last Closing Price: 18.95 (2025-05-23)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Rigel Pharmaceuticals, Inc. (RIGL) had Earnings per Share (EPS) (Diluted) of $0.63 for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$53.33M
$11.45M
$4.41M
$48.92M
$40.56M
$12.77M
$-1.26M
$11.51M
$11.51M
$11.45M
$11.45M
$11.45M
$11.45M
$12.77M
$13.19M
17.81M
18.17M
$0.64
Earnings per Share (EPS) (Diluted)
$0.63
Balance Sheet Financials
$146.56M
$0.08M
$29.41M
$175.97M
$66.63M
$44.93M
$90.78M
$157.41M
$18.57M
$-7.95M
$18.57M
17.87M
Cash Flow Statement Financials
$-0.89M
$-10.55M
$0.48M
$56.75M
$45.78M
$-10.96M
$3.32M
--
--
Fundamental Metrics & Ratios
2.20
--
--
0.71
3.22
91.73%
23.95%
23.95%
--
21.58%
21.46%
$-0.89M
--
--
--
0.30
0.95
1.28
70.11
61.65%
-144.07%
6.50%
18.03%
$1.04
$-0.05
$-0.05